Literature DB >> 32432925

Extracellular adenosine enhances pulmonary artery vasa vasorum endothelial cell barrier function via Gi/ELMO1/Rac1/PKA-dependent signaling mechanisms.

Alexander D Verin1, Robert Batori1, Anita Kovacs-Kasa1, Mary Cherian-Shaw1, Sanjiv Kumar1, Istvan Czikora1, Vijaya Karoor2, Derek Strassheim2, Kurt R Stenmark3, Evgenia V Gerasimovskaya3.   

Abstract

The vasa vasorum (VV), the microvascular network around large vessels, has been recognized as an important contributor to the pathological vascular remodeling in cardiovascular diseases. In bovine and rat models of hypoxic pulmonary hypertension (PH), we have previously shown that chronic hypoxia profoundly increased pulmonary artery (PA) VV permeability, associated with infiltration of inflammatory and progenitor cells in the arterial wall, perivascular inflammation, and structural vascular remodeling. Extracellular adenosine was shown to exhibit a barrier-protective effect on VV endothelial cells (VVEC) via cAMP-independent mechanisms, which involved adenosine A1 receptor-mediated activation of Gi-phosphoinositide 3-kinase-Akt pathway and actin cytoskeleton remodeling. Using VVEC isolated from the adventitia of calf PA, in this study we investigated in more detail the mechanisms linking Gi activation to downstream barrier protection pathways. Using a small-interference RNA (siRNA) technique and transendothelial electrical resistance assay, we found that the adaptor protein, engulfment and cell motility 1 (ELMO1), the tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2, and atypical Gi- and Rac1-mediated protein kinase A activation are implicated in VVEC barrier enhancement. In contrast, the actin-interacting GTP-binding protein, girdin, and the p21-activated kinase 1 downstream target, LIM kinase, are not involved in this response. In addition, adenosine-dependent cytoskeletal rearrangement involves activation of cofilin and inactivation of ezrin-radixin-moesin regulatory cytoskeletal proteins, consistent with a barrier-protective mechanism. Collectively, our data indicate that targeting adenosine receptors and downstream barrier-protective pathways in VVEC may have a potential translational significance in developing pharmacological approach for the VV barrier protection in PH.

Entities:  

Keywords:  Gi; Rac1; adenosine; endothelial barrier; vasa vasorum

Mesh:

Substances:

Year:  2020        PMID: 32432925      PMCID: PMC7468889          DOI: 10.1152/ajpcell.00505.2019

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  100 in total

1.  Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability.

Authors:  Teresa Sanchez; Tatiana Estrada-Hernandez; Ji-Hye Paik; Ming-Tao Wu; Krishnan Venkataraman; Volker Brinkmann; Kevin Claffey; Timothy Hla
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

2.  Pulmonary artery adventitial fibroblasts cooperate with vasa vasorum endothelial cells to regulate vasa vasorum neovascularization: a process mediated by hypoxia and endothelin-1.

Authors:  Neil J Davie; Evgenia V Gerasimovskaya; Stephen E Hofmeister; Aaron P Richman; Peter L Jones; John T Reeves; Kurt R Stenmark
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Molecular characterization of myosin phosphatase in endothelium.

Authors:  Kyung-Mi Kim; Csilla Csortos; Istvan Czikora; David Fulton; Nagavedi S Umapathy; Gabor Olah; Alexander D Verin
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

4.  Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation.

Authors:  Koji Kobayashi; Kanako Sato; Taiki Kida; Keisuke Omori; Masatoshi Hori; Hiroshi Ozaki; Takahisa Murata
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-06-12       Impact factor: 8.311

5.  Adenosine A1 receptor antagonist, L-97-1, improves survival and protects the kidney in a rat model of cecal ligation and puncture induced sepsis.

Authors:  Constance N Wilson; Constance O Vance; Melissa G Lechner; George M Matuschak; Andrew J Lechner
Journal:  Eur J Pharmacol       Date:  2014-07-18       Impact factor: 4.432

Review 6.  In vitro and in vivo modulation of vascular barrier integrity by sphingosine 1-phosphate: mechanistic insights.

Authors:  Bryan J McVerry; Joe G N Garcia
Journal:  Cell Signal       Date:  2005-02       Impact factor: 4.315

7.  Glycogen synthase kinase 3β inhibition prevents monocyte migration across brain endothelial cells via Rac1-GTPase suppression and down-regulation of active integrin conformation.

Authors:  Slava Rom; Shongshan Fan; Nancy Reichenbach; Holly Dykstra; Servio H Ramirez; Yuri Persidsky
Journal:  Am J Pathol       Date:  2012-08-03       Impact factor: 4.307

Review 8.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

9.  The protective role of MLCP-mediated ERM dephosphorylation in endotoxin-induced lung injury in vitro and in vivo.

Authors:  Anita Kovacs-Kasa; Boris A Gorshkov; Kyung-Mi Kim; Sanjiv Kumar; Stephen M Black; David J Fulton; Christiana Dimitropoulou; John D Catravas; Alexander D Verin
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

10.  Resolvin D1 via prevention of ROS-mediated SHP2 inactivation protects endothelial adherens junction integrity and barrier function.

Authors:  Rima Chattopadhyay; Somasundaram Raghavan; Gadiparthi N Rao
Journal:  Redox Biol       Date:  2017-03-06       Impact factor: 11.799

View more
  2 in total

Review 1.  On vasa vasorum: A history of advances in understanding the vessels of vessels.

Authors:  Julie A Phillippi
Journal:  Sci Adv       Date:  2022-04-20       Impact factor: 14.957

Review 2.  P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

Authors:  Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.